158 results on '"Regazzo, Daniela"'
Search Results
2. The compound pathogenic effects of a homozygous frameshift variant in the transmembrane region of GP9, causing Bernard–Soulier syndrome, with a missense variant in GP1BB.
3. Loss of KDM1A in GIP-dependent primary bilateral macronodular adrenal hyperplasia with Cushing's syndrome: a multicentre, retrospective, cohort study
4. Coexistence of multiple gene variants in some patients with erythrocytoses
5. KDM1A genotyping and expression in 146 sporadic somatotroph pituitary adenomas
6. A novel RUNX1 mutation with ANKRD26 dysregulation is related to thrombocytopenia in a sporadic form of myelodysplastic syndrome
7. Clinical presentation and management of acromegaly in elderly patients
8. A Novel Somatostatin Receptor Ligand for Human ACTH- and GH-secreting Pituitary Adenomas
9. Is pasireotide-induced diabetes mellitus predictable? A pilot study on the effect of a single dose of pasireotide on glucose homeostasis
10. Long-course temozolomide in aggressive pituitary adenoma: real-life experience in two tertiary care centers and review of the literature
11. The pathogenic role of the GIP/GIPR axis in human endocrine tumors: emerging clinical mechanisms beyond diabetes
12. OR17-05 Lysine Demethylase KDM1A And Ectopic Expression Of GIP-Receptor In Somatotropinomas Of Patients With Paradoxical Response To Oral Glucose
13. No von Willebrand factor domains other than A1 are involved in type 2B von Willebrand disease: what the p.R924Q and p.A2178S variants teach us
14. Lesioni ipofisarie nel Carney Complex
15. Role of Estrogen and Estrogen Receptor in GH-Secreting Adenomas
16. The Methylation Analysis of the Glucose-Dependent Insulinotropic Polypeptide Receptor (GIPR) Locus in GH-Secreting Pituitary Adenomas
17. Lysine demethylase KDM1A and ectopic expression of GIP-receptor in somatotropinomas of patients with paradoxical response to oral glucose
18. A novel somatostatin receptor ligand for human ACTH – and GH –secreting pituitary adenomas.
19. La gestione dei carriers nella iperplasia bilaterale surrenalica ARMC5 mutata
20. Targeted NGS analysis reveals a complex genetic background of idiopathic erythrocytosis in a large Venetian Family
21. Daily salivary cortisol and cortisone rhythm in patients with adrenal incidentaloma
22. Early recognition of aggressive pituitary adenomas: a single-centre experience
23. OR04-4 Loss of KDM1A in Bilateral Macronodular Adrenal Hyperplasia With GIP-Dependent Cushing's Syndrome and in Acromegaly With Paradoxical GH Response to Oral Glucose
24. Caratteristiche cliniche dei pazienti acromegalici con risposta paradossa di GH al carico orale di glucosio
25. Diagnostic accuracy of increased urinary cortisol/cortisone ratio to differentiate ACTH‐dependent Cushingʼs syndrome
26. The Role of Glucocorticoid Receptor in the Pathophysiology of Pituitary Corticotroph Adenomas
27. Loss of lysine demethylase KDM1A in GIP-dependent bilateral macronodular adrenal hyperplasia with Cushing's syndrome
28. The clinical and molecular evaluation of the GIP/GIPR axis in Medullary Thyroid Cancer (MTC)
29. The diagnosis of recurrence during postoperative follow-up of Cushing's disease
30. Incretin Response to Mixed Meal Challenge in Active Cushing’s Disease and after Pasireotide Therapy
31. The GIP/GIPR axis in medullary thyroid cancer: clinical and molecular findings
32. OR04-4 Loss of KDM1A in Bilateral Macronodular Adrenal Hyperplasia With GIP-Dependent Cushing's Syndrome and in Acromegaly With Paradoxical GH Response to Oral Glucose
33. Large Genomic Rearrangements of Desmosomal Genes in Italian Arrhythmogenic Cardiomyopathy Patients
34. OR04-4 Loss of KDM1A in Bilateral Macronodular Adrenal Hyperplasia With GIP-Dependent Cushing's Syndrome and in Acromegaly With Paradoxical GH Response to Oral Glucose
35. Diagnostic Accuracy of CT Texture Analysis in Adrenal Masses: A Systematic Review
36. Gonadotropin secreting pituitary adenoma associated with erythrocytosis: case report and literature review
37. Loss of KDM1A in GIP-dependent primary bilateral macronodular adrenal hyperplasia with Cushing's syndrome: a multicentre, retrospective, cohort study.
38. Fermented milks from Enterococcus faecalis TH563 and Lactobacillus delbrueckii subsp. bulgaricus LA2 manifest different degrees of ACE-inhibitory and immunomodulatory activities
39. Activation of the Dopamine Receptor Type-2 (DRD2) Promoter by 9-Cis Retinoic Acid in a Cellular Model of Cushingʼs Disease Mediates the Inhibition of Cell Proliferation and ACTH Secretion Without a Complete Corticotroph-to-Melanotroph Transdifferentiation
40. A novel RUNX1 mutation with ANKRD26 dysregulation is related to thrombocytopenia in a sporadic form of myelodysplastic syndrome
41. Clinical presentation and management of acromegaly in elderly patients
42. 9-CIS retinoic acid decreases pomc expression and cell viability in experimental model of ectopic cushing syndrome
43. Cardiovascular risk and metabolic profile in adult patients with congenital adrenal hyperplasia
44. Allelic Variants of ARMC5 in Patients With Adrenal Incidentalomas and in Patients With Cushing's Syndrome Associated With Bilateral Adrenal Nodules
45. The (193-209) 17-residues peptide of bovine β-casein is transported through Caco-2 monolayer
46. Effects of a single dose of pasireotide on glucose metabolism in patients with Cushing's disease and predictors of diabetes mellitus developement during treatment
47. Different therapeutic options in patients with Cushing's syndrome due to bilateral macronodular adrenal hyperplasia
48. Loss of KDM1Ain GIP-dependent primary bilateral macronodular adrenal hyperplasia with Cushing's syndrome: a multicentre, retrospective, cohort study
49. A novel RUNX1mutation with ANKRD26 dysregulation is related to thrombocytopenia in a sporadic form of myelodysplastic syndrome
50. Paradoxical GH Increase During OGTT Is Associated With First-Generation Somatostatin Analog Responsiveness in Acromegaly
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.